Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ABCB1 Single Nucleotide Polymorphism Genotypes as Predictors of Paclitaxel-Induced Peripheral Neuropathy in Breast Cancer

NCT05093023 is registered in ClinicalTrials.gov with Ain Shams University as lead sponsor.

NCT NCT05093023
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05093023 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ABCB1 Single Nucleotide Polymorphism Genotypes as Predictors of Paclitaxel-Induced Peripheral Neuropathy in Breast Cancer
Lead sponsor
Ain Shams University
Phase
Observational
Overall status
Completed
Start date
March 1, 2018
Completion date
January 31, 2020
Enrollment
92 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, neuropathy;peripheral, paclitaxel adverse reaction